Moderna, a drugmaker with simply a single product to its title, has turn into maybe the best-known biotech in the world over the previous 4 months, with almost 100 million doses of its Covid-19 vaccine administered in the U.S. alone.

Yet traders don’t appear to know what to make of it anymore, and the inventory is caught in a spin cycle.

In the first…